Effect of atazanavir administered with and without ritonavir on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 07 Apr 2011
At a glance
- Drugs Atazanavir (Primary) ; Ritonavir; Rosiglitazone
- Indications HIV infections; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 31 Aug 2018 Biomarkers information updated
- 31 Oct 2007 Status change from in progress to completed.
- 16 Nov 2006 New trial record.